Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK)
6821.HK Stock Price Chart
Explore Asymchem Laboratories (Tianjin) Co., Ltd. interactive price chart. Choose custom timeframes to analyze 6821.HK price movements and trends.
6821.HK Company Profile
Discover essential business fundamentals and corporate details for Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 Dec 2021
Employees
9.60K
Website
https://www.asymchem.com.cnCEO
Hao Hong
Description
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.
6821.HK Financial Timeline
Browse a chronological timeline of Asymchem Laboratories (Tianjin) Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 25 Aug 2025
EPS came in at $0.88 , while revenue for the quarter reached $1.79B , beating expectations by +1.59%.
Dividend declared on 25 Jun 2025
A dividend of $1.20 per share was announced, adjusted to $1.20. The dividend was paid on 25 Jul 2025.
Earnings released on 23 Apr 2025
EPS came in at $0.95 , while revenue for the quarter reached $1.64B .
Earnings released on 28 Mar 2025
EPS came in at $0.72 surpassing the estimated $0.26 by +175.74%, while revenue for the quarter reached $1.77B , missing expectations by -6.04%.
Earnings released on 29 Oct 2024
EPS came in at $0.66 falling short of the estimated $1.30 by -49.31%, while revenue for the quarter reached $1.60B , missing expectations by -3.18%.
Earnings released on 28 Aug 2024
EPS came in at $0.68 falling short of the estimated $1.08 by -36.67%, while revenue for the quarter reached $1.39B , missing expectations by -2.88%.
Dividend declared on 13 Jun 2024
A dividend of $1.98 per share was announced, adjusted to $1.98. The dividend was paid on 12 Jul 2024.
Earnings released on 25 Apr 2024
EPS came in at $0.82 falling short of the estimated $1.10 by -25.27%, while revenue for the quarter reached $1.51B , missing expectations by -4.34%.
Earnings released on 28 Mar 2024
EPS came in at $0.18 falling short of the estimated $0.46 by -60.77%, while revenue for the quarter reached $1.60B , missing expectations by -17.99%.
Earnings released on 30 Oct 2023
EPS came in at $1.55 surpassing the estimated $1.07 by +44.86%, while revenue for the quarter reached $1.89B , missing expectations by -11.40%.
Earnings released on 29 Aug 2023
EPS came in at $3.18 , while revenue for the quarter reached $2.57B , beating expectations by +2.31%.
Dividend declared on 15 Jun 2023
A dividend of $1.98 per share was announced, adjusted to $1.98. The dividend was paid on 21 Jul 2023.
Earnings released on 28 Apr 2023
EPS came in at $1.74 surpassing the estimated $1.54 by +12.99%, while revenue for the quarter reached $2.72B .
Earnings released on 30 Mar 2023
EPS came in at $1.96 surpassing the estimated $0.96 by +103.53%, while revenue for the quarter reached $2.57B , missing expectations by -8.46%.
Earnings released on 30 Sept 2022
EPS came in at $2.96 surpassing the estimated $1.49 by +98.66%, while revenue for the quarter reached $3.04B , beating expectations by +4.01%.
Stock split effective on 11 Jul 2022
Shares were split 7 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2022
EPS came in at $3.96 surpassing the estimated $3.76 by +5.32%, while revenue for the quarter reached $3.49B , beating expectations by +4.74%.
Dividend declared on 13 Jun 2022
A dividend of $0.94 per share was announced, adjusted to $0.67. The dividend was paid on 21 Jul 2022.
Earnings released on 31 Mar 2022
EPS came in at $1.68 surpassing the estimated $1.19 by +41.18%, while revenue for the quarter reached $2.54B , beating expectations by +24.32%.
Earnings released on 31 Dec 2021
EPS came in at $1.32 falling short of the estimated $1.63 by -19.02%, while revenue for the quarter reached $2.10B .
Earnings released on 26 Oct 2021
EPS came in at $0.95 , while revenue for the quarter reached $1.40B .
Earnings released on 15 Aug 2021
EPS came in at $0.97 , while revenue for the quarter reached $1.18B .
Earnings released on 29 Jun 2021
EPS came in at $0.75 , while revenue for the quarter reached $1.27B .
Earnings released on 31 Mar 2021
EPS came in at $0.54 , while revenue for the quarter reached $920.32M .
Earnings released on 30 Sept 2020
EPS came in at $0.67 , while revenue for the quarter reached $931.46M .
6821.HK Stock Performance
Access detailed 6821.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.